SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-19-000060
Filing Date
2019-11-12
Accepted
2019-11-12 16:21:13
Documents
74
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q haloq319-10q.htm   iXBRL 10-Q 1678972
2 EXHIBIT 31.1 ex311q319.htm EX-31.1 17201
3 EXHIBIT 31.2 ex312q319.htm EX-31.2 17249
4 EXHIBIT 32 ex32q319.htm EX-32 20010
10 slide1a92.jpg GRAPHIC 104154
11 slide2a78.jpg GRAPHIC 101076
  Complete submission text file 0001159036-19-000060.txt   7938264

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20190930.xsd EX-101.SCH 43971
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20190930_cal.xml EX-101.CAL 84161
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20190930_def.xml EX-101.DEF 203073
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20190930_lab.xml EX-101.LAB 585311
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20190930_pre.xml EX-101.PRE 351244
33 EXTRACTED XBRL INSTANCE DOCUMENT haloq319-10q_htm.xml XML 1420821
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 191209771
SIC: 2836 Biological Products, (No Diagnostic Substances)